JP2008543890A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008543890A5 JP2008543890A5 JP2008517321A JP2008517321A JP2008543890A5 JP 2008543890 A5 JP2008543890 A5 JP 2008543890A5 JP 2008517321 A JP2008517321 A JP 2008517321A JP 2008517321 A JP2008517321 A JP 2008517321A JP 2008543890 A5 JP2008543890 A5 JP 2008543890A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine
- pharmaceutical composition
- composition
- immunogenic
- mycobacterium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200500924 | 2005-06-23 | ||
| DKPA200500924 | 2005-06-23 | ||
| DKPA200501393 | 2005-10-05 | ||
| DKPA200501393 | 2005-10-05 | ||
| PCT/DK2006/000356 WO2006136162A2 (en) | 2005-06-23 | 2006-06-20 | Tuberculosis vaccines comprising antigens expressed during the latent infection phase |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013001657A Division JP2013121959A (ja) | 2005-06-23 | 2013-01-09 | 改良された結核ワクチン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008543890A JP2008543890A (ja) | 2008-12-04 |
| JP2008543890A5 true JP2008543890A5 (https=) | 2009-12-24 |
| JP5219808B2 JP5219808B2 (ja) | 2013-06-26 |
Family
ID=37134239
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008517321A Expired - Fee Related JP5219808B2 (ja) | 2005-06-23 | 2006-06-20 | 改良された結核ワクチン |
| JP2013001657A Pending JP2013121959A (ja) | 2005-06-23 | 2013-01-09 | 改良された結核ワクチン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013001657A Pending JP2013121959A (ja) | 2005-06-23 | 2013-01-09 | 改良された結核ワクチン |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US7968105B2 (https=) |
| EP (4) | EP2163255B1 (https=) |
| JP (2) | JP5219808B2 (https=) |
| KR (2) | KR101035053B1 (https=) |
| CN (1) | CN102836425B (https=) |
| AU (1) | AU2006261445B2 (https=) |
| BR (1) | BRPI0612833A2 (https=) |
| CA (2) | CA2612900C (https=) |
| ES (1) | ES2647070T3 (https=) |
| IL (3) | IL188222A (https=) |
| MX (1) | MX2007016165A (https=) |
| WO (1) | WO2006136162A2 (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19529931C1 (de) | 1995-08-02 | 1997-04-03 | Mannesmann Ag | Plattenkokille zur Erzeugung von Strängen aus Stahl |
| AU2003242504A1 (en) * | 2002-07-13 | 2004-02-02 | Statens Serum Institut | Therapeutic tuberculosis vaccines |
| ES2621211T3 (es) * | 2007-04-04 | 2017-07-03 | Infectious Disease Research Institute | Composiciones inmunogénicas que comprenden polipéptidos de mycobacterium tuberculosis y fusiones de los mismos |
| HRP20150177T1 (hr) * | 2007-04-12 | 2015-04-10 | Mico Bio, Inc. | Cjepivo protiv tuberkuloze i postupak upotrebe tog cjepiva |
| WO2009003474A1 (en) * | 2007-06-29 | 2009-01-08 | Statens Serum Institut | The use of monomycolyl glycerol (mmg) as an adjuvant |
| CN101969976A (zh) | 2008-01-11 | 2011-02-09 | 美国政府健康与人类服务部秘书处 | 针对分枝杆菌的多肽疫苗和接种策略 |
| US20100015171A1 (en) * | 2008-07-15 | 2010-01-21 | Statens Serum Institute | Vaccines comprising tb 10.4 |
| PT2315773T (pt) * | 2008-07-25 | 2016-11-23 | Glaxosmithkline Biologicals Sa | Polipéptidos, polinucleótidos e composições para utilização no tratamento de tuberculose latente |
| ES2588183T3 (es) * | 2009-03-31 | 2016-10-31 | Japan As Represented By Director-General Of National Institute Of Infectious Diseases | Procedimiento para la prevención de la gripe utilizando una vacuna para administración intranasal |
| ES2714383T3 (es) * | 2009-04-24 | 2019-05-28 | Statens Seruminstitut | Vacuna TB contra la tuberculosis para impedir la reactivación |
| CA2769645A1 (en) * | 2009-07-29 | 2011-02-03 | Bernd Helmut Adam Rehm | Polymer particles and uses thereof |
| CN104640564B (zh) | 2012-07-10 | 2020-08-04 | 特兰斯吉恩股份有限公司 | 分枝杆菌抗原疫苗 |
| RU2520078C1 (ru) * | 2013-04-25 | 2014-06-20 | Федеральное государственное бюджетное учреждение "Научно-исследовательский институт эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации (ФГБУ "НИИЭМ им. Н.Ф. Гамалеи" Минздрава России) | СПОСОБ ПОЛУЧЕНИЯ ИММУНОГЕННОЙ КОМПОЗИЦИИ НА ОСНОВЕ ГИБРИДНОГО БЕЛКА Ag85A-DBD И ДЕКСТРАНА, РЕКОМБИНАНТНАЯ ПЛАЗМИДА pAg85A-DBD, ШТАММ Escherichia coli [pREP4, pAg85A-DBD], ХИМЕРНЫЙ БЕЛОК Ag85A-DBD |
| RU2520737C1 (ru) * | 2013-04-25 | 2014-06-27 | Федеральное государственное бюджетное учреждение "Научно-исследовательский институт эпидемиологии и микробиологии имени почётного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации (ФГБУ "НИИЭМ им. Н.Ф. Гамалеи" Минздрава России) | СПОСОБ ПОЛУЧЕНИЯ ИММУНОГЕННОЙ КОМПОЗИЦИИ НА ОСНОВЕ ГИБРИДНОГО БЕЛКА pESAT6-DBD И ДЕКСТРАНА, РЕКОМБИНАНТНАЯ ПЛАЗМИДА pESAT6-DBD, ШТАММ Escherichia coli, ХИМЕРНЫЙ БЕЛОК ESAT6-DBD И ИХ ПРИМЕНЕНИЕ |
| RU2539026C1 (ru) * | 2013-06-11 | 2015-01-10 | Федеральное государственное бюджетное учреждение "Центральный научно-исследовательский институт туберкулеза" Российской академии медицинских наук | РЕКОМБИНАНТНАЯ ПЛАЗМИДА pESAT6-CFP10-DBD, РЕКОМБИНАНТНЫЙ ШТАММ Escherichia coli M15 [pREP4, pESAT6-CFP10-DBD], СПОСОБ ПОЛУЧЕНИЯ, ИММОБИЛИЗАЦИИ, КОНЦЕНТРИРОВАНИЯ И ОЧИСТКИ РЕКОМБИНАНТНОГО БЕЛКА ESAT6-CFP10-DBD НА ДЕКСТРАНЕ, РЕКОМБИНАНТНЫЙ БЕЛОК ESAT6-CFP10-DBD И ИММУНОГЕННАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ БЕЛОК ESAT6-CFP10-DBD |
| CN105431166B (zh) | 2013-06-25 | 2020-09-18 | 国际艾滋病疫苗行动组织公司 | 结核病组合物和其使用方法 |
| EP3092000A1 (en) | 2014-01-09 | 2016-11-16 | Transgene SA | Fusion of heterooligomeric mycobacterial antigens |
| US10428122B2 (en) * | 2016-06-16 | 2019-10-01 | International Aids Vaccine Initiative, Inc. | Tuberculosis compositions and methods of treating or preventing tuberculosis |
| CN107970444B (zh) * | 2016-10-25 | 2022-03-01 | 中国人民解放军第三0九医院 | 复合佐剂及含有该复合佐剂的疫苗 |
| CN114222762B (zh) * | 2019-06-14 | 2025-09-02 | 史坦恩斯血清研究所 | 用于结核疫苗的融合蛋白 |
| EP4217066A4 (en) * | 2020-09-23 | 2024-10-23 | The General Hospital Corporation | BCG VACCINES TO PREVENT COVID-19 AND OTHER INFECTIOUS DISEASES |
| KR102709729B1 (ko) * | 2020-12-04 | 2024-09-25 | 주식회사 제넥신 | 결핵의 예방 또는 치료용 약학적 조성물 |
| CN115598041B (zh) * | 2021-07-07 | 2025-08-19 | 中国科学院微生物研究所 | 结核鉴别诊断细胞因子及其在结核感染风险评估中的应用 |
| WO2023156676A1 (en) | 2022-02-21 | 2023-08-24 | Statens Serum Institut | A novel cationic adjuvant composition |
| CN117531001A (zh) * | 2023-11-15 | 2024-02-09 | 首都医科大学附属北京胸科医院 | 结核分枝杆菌毒素抗毒素系统及其相关应用 |
| CN118108815B (zh) * | 2024-04-23 | 2024-07-23 | 成都康华生物制品股份有限公司 | 结核分枝杆菌多免疫原抗原、编码其的mRNA、应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1331C (da) | 1897-11-15 | Hans Daae | Militær- og Skilygte. | |
| US4599230A (en) | 1984-03-09 | 1986-07-08 | Scripps Clinic And Research Foundation | Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
| US4599231A (en) | 1984-03-09 | 1986-07-08 | Scripps Clinic And Research Foundation | Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
| US4608251A (en) | 1984-11-09 | 1986-08-26 | Pitman-Moore, Inc. | LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues |
| US4601903A (en) | 1985-05-01 | 1986-07-22 | The United States Of America As Represented By The Department Of Health And Human Services | Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease |
| US6641814B1 (en) | 1997-04-02 | 2003-11-04 | Statens Serum Institut | Nucleic acids fragments and polypeptide fragments derived from M. tuberculosis |
| EP0784059B1 (en) * | 1994-09-20 | 2009-02-11 | Hitachi Chemical Co., Ltd. | Polynucleotides encoding an antigenic polypeptide of chlamydia pneumoniae |
| ATE339436T1 (de) | 1995-06-07 | 2006-10-15 | Sanofi Pasteur Inc | Expression von lipoproteinen |
| US20040018574A1 (en) * | 1998-08-25 | 2004-01-29 | Marcel Behr | Molecular differences between species of the M. tuberculosis complex |
| EP1218381B1 (en) | 1999-09-30 | 2006-12-06 | Neurogen Corporation | AMINO SUBSTITUTED PYRAZOLO¬1,5-a|-1,5-PYRIMIDINES AND PYRAZOLO¬1,5-a|-1,3,5-TRIAZINES |
| EP1278769A2 (en) | 2000-04-19 | 2003-01-29 | Statens Serum Institut | Tuberculosis antigens and methods of use thereof |
| US7288261B2 (en) | 2000-07-10 | 2007-10-30 | Colorado State University Research Foundation | Mid-life vaccine and methods for boosting anti-mycobacterial immunity |
| US20030180953A1 (en) * | 2000-12-29 | 2003-09-25 | Elitra Pharmaceuticals, Inc. | Gene disruption methodologies for drug target discovery |
| US20030119013A1 (en) * | 2001-04-23 | 2003-06-26 | Bo Jiang | Identification of essential genes of Aspergillus fumigatus and methods of use |
| EP2196473A1 (en) * | 2001-07-04 | 2010-06-16 | Health Protection Agency | Mycobacterial antigens expressed during latency |
| AU2003242504A1 (en) | 2002-07-13 | 2004-02-02 | Statens Serum Institut | Therapeutic tuberculosis vaccines |
-
2006
- 2006-06-20 CA CA2612900A patent/CA2612900C/en not_active Expired - Fee Related
- 2006-06-20 EP EP09172905.3A patent/EP2163255B1/en not_active Not-in-force
- 2006-06-20 EP EP06753317A patent/EP1910409A2/en not_active Withdrawn
- 2006-06-20 CN CN201210332759.0A patent/CN102836425B/zh not_active Expired - Fee Related
- 2006-06-20 EP EP11171153A patent/EP2380590A3/en not_active Withdrawn
- 2006-06-20 CA CA2836319A patent/CA2836319A1/en not_active Abandoned
- 2006-06-20 KR KR1020087001874A patent/KR101035053B1/ko not_active Expired - Fee Related
- 2006-06-20 AU AU2006261445A patent/AU2006261445B2/en not_active Ceased
- 2006-06-20 US US11/993,199 patent/US7968105B2/en not_active Expired - Fee Related
- 2006-06-20 JP JP2008517321A patent/JP5219808B2/ja not_active Expired - Fee Related
- 2006-06-20 ES ES09172905.3T patent/ES2647070T3/es active Active
- 2006-06-20 MX MX2007016165A patent/MX2007016165A/es active IP Right Grant
- 2006-06-20 EP EP11171143A patent/EP2380589A3/en not_active Withdrawn
- 2006-06-20 BR BRPI0612833-5A patent/BRPI0612833A2/pt not_active IP Right Cessation
- 2006-06-20 WO PCT/DK2006/000356 patent/WO2006136162A2/en not_active Ceased
- 2006-06-20 KR KR1020107024618A patent/KR101188045B1/ko not_active Expired - Fee Related
-
2007
- 2007-12-18 IL IL188222A patent/IL188222A/en not_active IP Right Cessation
-
2011
- 2011-05-05 US US13/101,980 patent/US8101193B2/en not_active Expired - Fee Related
- 2011-12-22 US US13/335,133 patent/US8293250B2/en not_active Expired - Fee Related
-
2012
- 2012-09-20 US US13/623,733 patent/US8703151B2/en not_active Expired - Fee Related
- 2012-11-07 IL IL222914A patent/IL222914A0/en unknown
- 2012-11-07 IL IL222915A patent/IL222915A0/en unknown
-
2013
- 2013-01-09 JP JP2013001657A patent/JP2013121959A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008543890A5 (https=) | ||
| JP2008539187A5 (https=) | ||
| US11224646B2 (en) | Intranasal delivery of a cyclic-di-nucleotide adjuvanted vaccine for tuberculosis | |
| Kim et al. | Treatment of latent tuberculosis infection and its clinical efficacy | |
| Ingolotti et al. | DNA vaccines for targeting bacterial infections | |
| JP2013507907A5 (https=) | ||
| JP2008530245A5 (https=) | ||
| HRP20120331T1 (hr) | Postupak sprječavanja ili liječenja infekcije bakterijom m. tuberculosis | |
| Huygen | On the use of DNA vaccines for the prophylaxis of mycobacterial diseases | |
| JP2008529558A5 (https=) | ||
| EP3134116B1 (en) | New m.tuberculosis vaccines | |
| KR20170072366A (ko) | 재활성화를 예방하기 위한 결핵 백신 | |
| BRPI0905725B1 (pt) | vacina e embalagem farmacêutica | |
| RU2016146801A (ru) | Вакцинная композиция против инфекции, вызванной streptococcus suis | |
| JP2015536309A (ja) | 結核菌（ｍ．ｔｕｂｅｒｃｕｌｏｓｉｓ）ワクチン | |
| Kaufmann | Tuberculosis vaccine development at a divide | |
| CN101745104A (zh) | 含有复合佐剂的结核亚单位疫苗 | |
| WO2016201825A1 (zh) | 结核分枝杆菌抗原及其应用 | |
| WO2005061534A3 (en) | Improved tuberculosis vaccines | |
| CN101451145A (zh) | 基于t细胞表位的结核基因疫苗及其制备方法和应用 | |
| Mobed | DNA Based vaccines against Mycobacterium tuberculosis: recent progress in vaccine development and delivery system | |
| Avarvand et al. | The roles of latency-associated antigens in tuberculosis vaccines | |
| AU2006204382B2 (en) | Compositions for immunizing against mycobacterium | |
| BR112012011395B1 (pt) | Uso de uma fonte de l3 e/ou l5 como uma vacina ou como um diagnóstico para uma doença parasítica | |
| Li et al. | Improved humoral immunity against tuberculosis ESAT-6 antigen by chimeric DNA prime and protein boost strategy |